Insider Transactions in Q3 2022 at Day One Biopharmaceuticals, Inc. (DAWN)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 21
2022
|
Papanek Julie Grant Director |
SELL
Other acquisition or disposition
|
Indirect |
1,500,000
-17.72%
|
-
|
|
Sep 21
2022
|
Papanek Julie Grant Director |
SELL
Open market or private sale
|
Indirect |
613,603
-3.38%
|
$11,044,854
$18.92 P/Share
|
|
Sep 21
2022
|
Canaan Xi L.P. > 10% Shareholder |
SELL
Other acquisition or disposition
|
Direct |
1,500,000
-17.72%
|
-
|
|
Sep 21
2022
|
Canaan Xi L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
613,603
-3.38%
|
$11,044,854
$18.92 P/Share
|
|
Sep 20
2022
|
Papanek Julie Grant Director |
SELL
Open market or private sale
|
Indirect |
148,670
-0.81%
|
$2,824,730
$19.8 P/Share
|
|
Sep 20
2022
|
Canaan Xi L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
148,670
-0.81%
|
$2,824,730
$19.8 P/Share
|
|
Sep 19
2022
|
Atlas Venture Fund Xi, L.P. > 10% Shareholder |
SELL
Other acquisition or disposition
|
Direct |
600,854
-8.33%
|
-
|
|
Sep 19
2022
|
Papanek Julie Grant Director |
SELL
Open market or private sale
|
Indirect |
76,725
-0.82%
|
$1,534,500
$20.57 P/Share
|
|
Sep 19
2022
|
Canaan Xi L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
76,725
-0.82%
|
$1,534,500
$20.57 P/Share
|
|
Sep 16
2022
|
Papanek Julie Grant Director |
SELL
Open market or private sale
|
Indirect |
115,307
-0.61%
|
$2,421,447
$21.79 P/Share
|
|
Sep 16
2022
|
Canaan Xi L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
115,307
-0.61%
|
$2,421,447
$21.79 P/Share
|
|
Sep 15
2022
|
Canaan Xi L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
51,281
-0.27%
|
$1,179,463
$23.26 P/Share
|
|
Sep 15
2022
|
Papanek Julie Grant Director |
SELL
Open market or private sale
|
Indirect |
51,281
-0.27%
|
$1,179,463
$23.26 P/Share
|
|
Sep 14
2022
|
Canaan Xi L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
106,111
-0.55%
|
$2,440,553
$23.99 P/Share
|
|
Sep 14
2022
|
Papanek Julie Grant Director |
SELL
Open market or private sale
|
Indirect |
106,111
-0.55%
|
$2,440,553
$23.99 P/Share
|
|
Sep 13
2022
|
Canaan Xi L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
87,647
-0.45%
|
$2,103,528
$24.7 P/Share
|
|
Sep 13
2022
|
Papanek Julie Grant Director |
SELL
Open market or private sale
|
Indirect |
87,647
-0.45%
|
$2,103,528
$24.7 P/Share
|
|
Sep 02
2022
|
Papanek Julie Grant Director |
SELL
Open market or private sale
|
Indirect |
5,000
-1.13%
|
$115,000
$23.82 P/Share
|
|
Sep 01
2022
|
Charles N York Ii COO, CFO AND SECRETARY |
SELL
Open market or private sale
|
Direct |
10,000
-1.55%
|
$230,000
$23.48 P/Share
|
|
Sep 01
2022
|
Papanek Julie Grant Director |
SELL
Open market or private sale
|
Indirect |
5,000
-0.56%
|
$115,000
$23.5 P/Share
|
|
Sep 01
2022
|
Samuel C. Blackman HEAD OF R&D |
SELL
Open market or private sale
|
Direct |
10,000
-0.39%
|
$230,000
$23.47 P/Share
|
|
Sep 01
2022
|
Jeremy Bender CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
25,000
-0.5%
|
$575,000
$23.47 P/Share
|
|
Aug 16
2022
|
Charles N York Ii COO, CFO AND SECRETARY |
SELL
Open market or private sale
|
Direct |
1,089
-0.33%
|
$26,136
$24.31 P/Share
|
|
Aug 16
2022
|
Samuel C. Blackman HEAD OF R&D |
SELL
Open market or private sale
|
Direct |
941
-0.07%
|
$22,584
$24.31 P/Share
|
|
Aug 16
2022
|
Jeremy Bender CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
4,003
-0.32%
|
$96,072
$24.31 P/Share
|
|
Aug 15
2022
|
Charles N York Ii COO, CFO AND SECRETARY |
BUY
Exercise of conversion of derivative security
|
Direct |
4,125
+1.25%
|
-
|
|
Aug 15
2022
|
Samuel C. Blackman HEAD OF R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
3,561
+0.27%
|
-
|
|
Aug 15
2022
|
Jeremy Bender CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
10,686
+0.84%
|
-
|
|
Aug 05
2022
|
Papanek Julie Grant Director |
SELL
Open market or private sale
|
Indirect |
5,000
-1.1%
|
$100,000
$20.0 P/Share
|
|
Aug 04
2022
|
Papanek Julie Grant Director |
SELL
Open market or private sale
|
Indirect |
5,000
-1.09%
|
$100,000
$20.0 P/Share
|
|
Aug 04
2022
|
Jeremy Bender CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
12,500
-0.99%
|
$250,000
$20.0 P/Share
|
|
Aug 04
2022
|
Charles N York Ii COO, CFO AND SECRETARY |
SELL
Open market or private sale
|
Direct |
10,000
-3.02%
|
$200,000
$20.05 P/Share
|
|
Aug 01
2022
|
Samuel C. Blackman HEAD OF R&D |
SELL
Open market or private sale
|
Direct |
10,000
-0.77%
|
$160,000
$16.88 P/Share
|
|
Jul 18
2022
|
Charles N York Ii COO, CFO AND SECRETARY |
SELL
Open market or private sale
|
Direct |
2,500
-0.75%
|
$50,000
$20.0 P/Share
|
|
Jul 18
2022
|
Papanek Julie Grant Director |
SELL
Open market or private sale
|
Indirect |
2,600
-0.56%
|
$52,000
$20.0 P/Share
|
|
Jul 18
2022
|
Jeremy Bender CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
2,600
-0.21%
|
$52,000
$20.0 P/Share
|
|
Jul 08
2022
|
Papanek Julie Grant Director |
SELL
Open market or private sale
|
Indirect |
1,242
-0.27%
|
$24,840
$20.0 P/Share
|
|
Jul 08
2022
|
Charles N York Ii COO, CFO AND SECRETARY |
SELL
Open market or private sale
|
Direct |
1,416
-0.42%
|
$28,320
$20.0 P/Share
|
|
Jul 08
2022
|
Jeremy Bender CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
1,795
-0.14%
|
$35,900
$20.0 P/Share
|
|
Jul 05
2022
|
Charles N York Ii COO, CFO AND SECRETARY |
SELL
Open market or private sale
|
Direct |
800
-0.24%
|
$16,000
$20.0 P/Share
|
|
Jul 05
2022
|
Papanek Julie Grant Director |
SELL
Open market or private sale
|
Indirect |
800
-0.17%
|
$16,000
$20.0 P/Share
|
|
Jul 05
2022
|
Jeremy Bender CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
857
-0.07%
|
$17,140
$20.0 P/Share
|
|
Jul 01
2022
|
Charles N York Ii COO, CFO AND SECRETARY |
SELL
Open market or private sale
|
Direct |
1,479
-0.44%
|
$29,580
$20.0 P/Share
|
|
Jul 01
2022
|
Papanek Julie Grant Director |
SELL
Open market or private sale
|
Indirect |
1,000
-0.22%
|
$20,000
$20.0 P/Share
|
|
Jul 01
2022
|
Samuel C. Blackman HEAD OF R&D |
SELL
Open market or private sale
|
Direct |
10,000
-0.25%
|
$190,000
$19.14 P/Share
|
|
Jul 01
2022
|
Jeremy Bender CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
1,746
-0.14%
|
$34,920
$20.0 P/Share
|
|
Jul 01
2022
|
Atlas Venture Opportunity Fund I, L.P. > 10% Shareholder |
SELL
Other acquisition or disposition
|
Direct |
198,280
-20.0%
|
-
|